How have HNL shares performed in 2024?

Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL stock has increased by 13.7% and is now trading at €19.90. View the best growth stocks for 2024 here .

Is Dr. Hönle a good dividend stock?

Dr. Hönle (ETR:HNL) pays an annual dividend of €0.20 per share and currently has a dividend yield of 1.09%.

ETR:HNL

Dr. Hönle (HNL) Stock Price, News & Analysis

→ Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad)

Free HNL Stock Alerts

€19.90

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: €19.60
▼
€20.00
50-Day Range: €15.35
▼
€20.20
52-Week Range: €15.00
▼
€24.50

Volume: 5,963 shs
Average Volume: N/A
Market Capitalization: $120.59 million

P/E Ratio: N/A
Dividend Yield: 1.01%
Price Target: N/A

Stock Analysis Chart Headlines

Get Dr. Hönle alerts:

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

About Dr. Hönle Stock (ETR:HNL)

Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.

HNL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HNL Stock News Headlines

April 18, 2024 | finanznachrichten.de

PTA-AFR: Dr. Hönle AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG

March 25, 2024 | finance.yahoo.com

Dr. Hönle AG's (ETR:HNL) top owners are retail investors with 54% stake, while 25% is held by private companies

April 18, 2024 | Insiders Exposed (Ad)

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

February 27, 2024 | finance.yahoo.com

Dr. Hönle First Quarter 2024 Earnings: €0.15 loss per share (vs €0.26 profit in 1Q 2023)

February 15, 2024 | health.usnews.com

Dr. Susan N. Mizuno

February 6, 2024 | travel.usnews.com

Free Things To Do in Honolulu - Oahu

February 4, 2024 | finance.yahoo.com

Dr Hoenle AG (HNL.HM)

February 4, 2024 | finance.yahoo.com

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

April 18, 2024 | Darwin (Ad)

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

February 3, 2024 | morningstar.com

Dr Hoenle AG HNL

December 20, 2023 | au.finance.yahoo.com

Dr. Hönle AG (HNL.F)

December 2, 2023 | travel.usnews.com

Getting Around Honolulu - Oahu

November 15, 2023 | finance.yahoo.com

Should You Investigate Dr. Hönle AG (ETR:HNL) At €18.25?

October 24, 2023 | msn.com

This Hawaii dermatologist didn’t realize it then, but his call helped his patient beat cancer

October 24, 2023 | finance.yahoo.com

Calculating The Intrinsic Value Of Dr. Hönle AG (ETR:HNL)

October 5, 2023 | finance.yahoo.com

Further weakness as Dr. Hönle (ETR:HNL) drops 10% this week, taking five-year losses to 75%

September 21, 2023 | health.usnews.com

Dr. Lyle T. Tenjoma

September 1, 2023 | finance.yahoo.com

Dr. Hönle AG's (ETR:HNL) top owners are individual investors with 60% stake, while 20% is held by institutions

August 17, 2023 | health.usnews.com

Dr. Andrew Inaba

August 12, 2023 | health.usnews.com

Dr. Weilin Bono

August 2, 2023 | health.usnews.com

Dr. John Ha

July 29, 2023 | health.usnews.com

Dr. James S. Tamai

July 29, 2023 | health.usnews.com

Dr. Peter Kyriakakis

July 22, 2023 | health.usnews.com

Dr. Michael R. Umaki

July 22, 2023 | health.usnews.com

Dr. Samuel M. Ishimura

July 20, 2023 | health.usnews.com

Dr. Reid T. Koyanagi

July 20, 2023 | health.usnews.com

Dr. Russell S. Tabata

See More Headlines

Receive HNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ETR
Sector: Industrials
Industry: Electrical Equipment & Parts
Sub-Industry: N/A
Current Symbol: ETR:HNL
CUSIP: N/A
CIK: N/A
Web: www.hoenle.de
Phone: 49 89 85608 0
Fax: N/A
Employees: 581
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): (€2.34)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 13.92
P/E Growth: -0.39
Net Income: $-13,830,000.00
Net Margins: -13.48%
Pretax Margin: N/A
Return on Equity: -13.56%
Return on Assets: 1.09%

Debt

Debt-to-Equity Ratio: 58.79
Current Ratio: 2.19
Quick Ratio: 0.85

Sales & Book Value

Annual Sales: $102.56 million
Price / Sales: 1.18
Cash Flow: €1.02 per share
Price / Cash Flow: 19.54
Book Value: €15.38 per share
Price / Book: 1.29

Miscellaneous

Outstanding Shares: 6,060,000
Free Float: N/A
Market Cap: $120.59 million
Optionable: Not Optionable
Beta: 1.48

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Franz Richter (Age 69)
Chairman of the Management Board, MD & CEO
Comp: $374.4k
Peter Weinert
Head of Investor Relations

Key Competitors

View All Competitors

HNL Stock Analysis - Frequently Asked Questions

How have HNL shares performed in 2024?: Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL stock has increased by 13.7% and is now trading at €19.90.
View the best growth stocks for 2024 here.
Is Dr. Hönle a good dividend stock?: Dr. Hönle (ETR:HNL) pays an annual dividend of €0.20 per share and currently has a dividend yield of 1.09%.

This page (ETR:HNL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial